Gendell Jeffrey L’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.7M Buy
1,090,973
+442,513
+68% +$6.32M 0.11% 62
2026
Q1
$10.9M Hold
648,460
0.15% 58
2025
Q4
$10.4M Buy
648,460
+78,989
+14% +$1.18M 0.18% 48
2025
Q3
$7.04M Hold
569,471
0.13% 51
2025
Q2
$6.56M Buy
569,471
+112,475
+25% +$1.33M 0.17% 32
2025
Q1
$6.85M Buy
456,996
+26,835
+6% +$449K 0.3% 26
2024
Q4
$7.45M Sell
430,161
-30,561
-7% -$590K 0.23% 38
2024
Q3
$8.54M Buy
460,722
+9,095
+2% +$183K 0.27% 34
2024
Q2
$9.16M Buy
451,627
+124,737
+38% +$2.21M 0.32% 37
2024
Q1
$5.58M Buy
326,890
+164,797
+102% +$2.59M 0.22% 46
2023
Q4
$2.86M Buy
162,093
+42,140
+35% +$849K 0.16% 52
2023
Q3
$2.88M Buy
119,953
+44,953
+60% +$1.1M 0.16% 51
2023
Q2
$1.74M Sell
75,000
-144,569
-66% -$3.27M 0.14% 48
2023
Q1
$4.84M Buy
219,569
+26,983
+14% +$631K 0.45% 31
2022
Q4
$3.9M Buy
+192,586
New +$3.73M 0.35% 34

Other funds holding CLB

Gendell Jeffrey L's CLB Position: Q2 2026 in Review

Gendell Jeffrey L increased its Core Laboratories (CLB) stake by 68% in Q2 2026, buying an estimated $6.32M and bringing the position to 1,090,973 shares worth $12.7M. The position accounts for 0.11% of the portfolio, ranked #62.

Gendell Jeffrey L first reported a position in CLB in Q4 2022 and has held it in 15 quarters since. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Gendell Jeffrey L held 1,090,973 shares of Core Laboratories worth $12.7M as of Q2 2026.
  • Gendell Jeffrey L bought 442,513 Core Laboratories shares in Q2 2026, an estimated $6.32M.
  • Core Laboratories made up 0.11% of Gendell Jeffrey L's portfolio in Q2 2026, its #62 holding.
  • Gendell Jeffrey L first reported a position in Core Laboratories in Q4 2022 and has held it in 15 quarters since.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Gendell Jeffrey L's 13F filing for Q2 2026, filed 14 Aug 2026.